methoxyhydroxyphenylglycol has been researched along with alprazolam in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (72.22) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breier, A; Buchanan, R; Davis, O; Goldstein, DS; Holmes, C; Listwak, SJ; Pickar, D | 1 |
| Cole, JO; Gerson, B; Mooney, JJ; Pappalardo, KM; Samson, JA; Schatzberg, AF; Schildkraut, JJ; Waternaux, C | 1 |
| Jolkkonen, J; Lepola, U; Riekkinen, P; Rimón, R | 1 |
| Golden, RN; Hsiao, JK; Potter, WZ; Risby, ED | 1 |
| Cook, B; Garvey, M; Noyes, R; Tollefson, G | 1 |
| Edlund, MJ; Swann, AC | 1 |
| Cole, JO; Gerson, B; Mooney, JJ; Schatzberg, AF; Schildkraut, JJ | 1 |
| Charney, DS; Heninger, GR | 1 |
| Carr, DB; Coleman, JH; Greenblatt, DJ; Heninger, GR; Jones, KJ; Levine, PH; Sheehan, DV; Surman, OS; Watkins, WD | 1 |
| Charney, DS; Goodman, WK; Heninger, GR; Price, LH; Woods, SW | 1 |
| Cowley, DS; Dager, SR; Dunner, DL | 1 |
| Breier, A; Charney, DS; Heninger, GR; Jatlow, PI | 1 |
| Bauer, K; Filser, JG; Fischer, M; Gattaz, WF; Müller, WE; Rost, W | 1 |
| Bauer, K; Gattaz, WF; Hübner, CK; Müller, WE; Rost, W | 1 |
| Coleman, JH; Greenblatt, DJ; Jones, KJ; Levine, PH; Orsulak, PJ; Peterson, M; Schildkraut, JJ; Sheehan, DV; Uzogara, E; Watkins, D | 1 |
| Benson, KL; Csernansky, JG; Faull, KF; Greene, KA; Zarcone, VP | 1 |
| Harano, M; Maeda, H; Miki, K; Nakamura, J; Shoji, H; Tanaka, M; Tsuda, A; Yajima, J; Yamada, S | 1 |
| Maeda, H; Tanaka, M; Tsuda, A; Yajima, J; Yamada, S; Yamauchi, K | 1 |
9 trial(s) available for methoxyhydroxyphenylglycol and alprazolam
| Article | Year |
|---|---|
Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans.
Topics: Adrenocorticotropic Hormone; Adult; Affect; Alprazolam; Arousal; Blood Glucose; Deoxyglucose; Epinephrine; Female; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Pituitary-Adrenal System; Stress, Physiological | 1992 |
Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; beta-Endorphin; Clinical Trials as Topic; Double-Blind Method; Fear; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Imipramine; Long-Term Care; Male; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Somatostatin | 1989 |
Intravenous alprazolam challenge in normal subjects. Biochemical, cardiovascular, and behavioral effects.
Topics: Adrenocorticotropic Hormone; Adult; Alprazolam; Animals; Female; Hemodynamics; Hormones; Humans; Injections, Intravenous; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Pentobarbital | 1989 |
Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.
Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; beta-Endorphin; Endorphins; Epinephrine; Fear; Female; Growth Hormone; Hospitalization; Humans; Infusions, Parenteral; Lactates; Lactic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Placebos; Platelet Factor 4; Prolactin; Prostaglandins; Psychiatric Status Rating Scales; Sex Factors | 1986 |
Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Pressure; Clinical Trials as Topic; Clonidine; Double-Blind Method; Female; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Pilot Projects; Substance Withdrawal Syndrome | 1986 |
Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.
Topics: Adult; Affect; Alprazolam; Behavior; Benzodiazepines; Blood Pressure; Diastole; Female; Glycols; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Systole; Yohimbine | 1986 |
Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; beta-Thromboglobulin; Blood Platelets; Fear; Female; Humans; Ibuprofen; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Panic; Phobic Disorders; Platelet Factor 4; Psychological Tests; Thromboxane B2 | 1984 |
The effect of chronic alprazolam on sleep and bioamine metabolites in depression.
Topics: Adult; Alprazolam; Depressive Disorder; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Personality Inventory; Polysomnography; Sleep Stages; Sleep, REM | 1994 |
Saliva level of free 3-methoxy-4-hydroxyphenylglycol in psychiatric outpatients with anxiety.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Saliva | 1998 |
9 other study(ies) available for methoxyhydroxyphenylglycol and alprazolam
| Article | Year |
|---|---|
Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.
Topics: Adult; Alprazolam; Bipolar Disorder; Depressive Disorder; Female; Follow-Up Studies; Humans; Imipramine; Male; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Psychometrics | 1991 |
The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Fear; Glycols; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Random Allocation | 1989 |
Low MHPG and continuing treatment in panic disorder.
Topics: Adult; Age Factors; Alprazolam; Fear; Female; Glycols; Humans; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Psychiatric Status Rating Scales | 1989 |
Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam.
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depressive Disorder; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Probability; Psychiatric Status Rating Scales | 1985 |
Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Pressure; Brain; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Receptors, Adrenergic, alpha; Receptors, GABA-A; Sympathetic Nervous System; Synaptic Transmission; Time Factors; Yohimbine | 1985 |
Biological markers in panic states: lactate-induced panic and mitral valve prolapse.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Creatinine; Diazepam; Double-Blind Method; Fear; Humans; Lactates; Lactic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Mitral Valve Prolapse; Panic | 1987 |
Urinary MHPG-sulfate and urinary MHPG-glucuronide, two possible markers of the central or peripheral norepinephrine metabolism in man. The effect of alprazolam treatment.
Topics: Alprazolam; Biomarkers; Depressive Disorder; Glycols; Humans; Methoxyhydroxyphenylglycol; Norepinephrine | 1988 |
Alprazolam response in major depression: relationship with urinary levels of MHPG-sulfate.
Topics: Adult; Alprazolam; Biomarkers; Depressive Disorder; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales | 1988 |
[Saliva level of free-3-methoxy-4-hydroxyphenylglycol in patients with anxiety disorders].
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Biomarkers; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Saliva | 1999 |